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Abstract 
Autonomic adjustments during exercise include a withdrawal of parasympathetic stimulation of 
the heart and an increase in the sympathetic stimulation of the heart and other organs/vascular 
beds. These adjustments are mediated, in part, by the exercise pressor reflex, a neural feedback 
mechanism activated by stimulation of group III and group IV afferents whose sensory endings 
are located within contracting skeletal muscle. Group III (mechanoreflex) and group IV 
(metaboreflex) afferents are primarily mechanically and metabolically sensitive, respectively. 
Cyclooxygenase (COX) products within skeletal muscles have the potential to sensitize the 
mechanical component of the exercise pressor reflex (i.e., mechanoreflex) in a variety of clinical 
populations including peripheral artery disease patients. For example, we found recently that 
COX inhibition reduced the pressor response evoked during hindlimb muscle stretch, a model of 
isolated mechanoreflex activation, in rats in which a femoral artery was ligated ~72 hours before 
the experiment (a model of simulated PAD in the rat). Conversely, we found no effect of COX 
inhibition on the mechanoreflex in normal, control rats. To investigate a potential mechanism of 
COX-mediated mechanoreflex sensitization in rats with ligated femoral arteries, we used the 
muscle microdialysis technique to test the hypothesis that femoral artery ligation in the rat 
increased resting skeletal muscle interstitial concentrations of the COX-metabolite prostaglandin 
E₂ (PGE₂). Contrary to our hypothesis, in 12 rats we found no difference in resting PGE₂ 
between control (i.e., freely perfused, 196±33 pg/ml) and the contralateral ligated (236±43 
pg/ml, p=0.15) hindlimb. Moreover, we found that hindlimb muscle stretch increased PGE₂ 
concentration in freely perfused skeletal muscles (Δ PGE₂: 55±22 pg/ml, p=0.05) but not ligated 
(Δ PGE₂: 19±20 pg/ml, p=0.98) skeletal muscles. Collectively, the present results suggest that 
COX-mediated mechanoreflex sensitization in the ligated rat model of simulated PAD is not 
  
attributable to elevated resting COX-metabolite levels or an exaggerated increase in COX-
metabolite concentration during isolated mechanoreflex activation. 
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Chapter 1 -  Literature Review 
Assessment of metabolites and other chemical compounds allow insight into normal 
homeostatic function and functional alterations that occur with progression of disease. 
Quantification of these metabolites allows investigators to tease apart the mechanisms 
underlying disease responses throughout the body. With developments in microdialysis, it is now 
possible to analyze a wide range of biological compounds across multiple species of 
experimental subjects. Microdialysis also offers the convenience of use in multiple tissue sites to 
further the understanding of systemic and local metabolite responses over time. This review will 
focus on the history and general concepts of microdialysis.  
Microdialysis is an experimental technique in which a probe with a semipermeable 
membrane is placed within a tissue of interest (brain, skin, fat or muscle) and a solution, or 
‘perfusate,’ is pumped through. This allows diffusion of metabolites and other biological 
compounds, which can be collected as a fluid termed, ‘dialysate’ (29, 56, 57). This fluid can be 
further analyzed and reflect concentrations from the site of interest. Bito et. al (1966) were the 
first to make use of a dialysis bag within the interstitial space (6). Microdialysis probes were then 
created by Delgado et. al (1972) and combined with perfusion of a solution via a dialysis bag 
carried to a specific site (13).  
Early microdialysis investigations focused on the brain, specifically to measure 
neurotransmitter concentrations and the ability of pharmacological interventions to penetrate the 
blood brain barrier (13, 29, 56). This technique was further adapted for use in other tissues, 
mainly a decrease in probe size to expand applicable uses (29). An advantage of microdialysis is 
the ability to make effective comparisons using a limited sample size, and in some instances 
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perform multiple comparisons within the same animal (35). Microdialysis allows the 
measurement of dynamic changes over time while maintaining the surrounding physiological 
environment. 
Microdialysis Technique 
         The earliest method of microdialysis employed a ‘push pull’ technique, where liquid was 
flushed directly through the tissue of interest in both directions to measure the contents of 
extracellular fluid (55). Following tissue disruption, if the proper balance of pushing and pulling 
was not achieved brain matter was removed during dialysate collection. As the technique 
progressed, a unidirectional flow pattern was adopted and microdialysis membranes were 
constructed in order to behave more similarly to a capillary. 
A linear design is most common in skin and tissue investigation, where a membrane open 
on both ends is attached to tubing on each side (56, 65). In investigations of the brain, concentric 
probes are commonly used due to the stability and durability of the design. This probe type 
consists of a semi-permeable membrane with a single opening that forks in order to allow 
separate flow of solution into and out of the membrane. Loop probes, similar to the design of 
linear probes, side-by-side, and shunt probes are also commonly used. Probe types and design 
vary between investigations, and the benefits of each are dependent upon specific experimental 
conditions (29, 47). 
         Membrane length is critical in establishing how much of the probe is in direct contact 
with the tissue of interest. Microdialysis is primarily a diffusion-limited technique. Increased 
length allows a greater area of contact, but poses the challenge of greater insult to the site of 
interest (39, 47). There is also concern over the efficacy of probe placement as it becomes more 
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difficult to control for exact measurements at a specific target site. Membranes typically have a 
molecular weight (MW) cutoff, in which molecules exceeding the specified range cannot diffuse 
across the membrane or trace amounts recovered are negligible due to slow perfusion (58). A 
large molecular cut off is not believed to hinder the ability of a membrane to diffuse smaller 
molecules. Previous investigations have suggested that microdialysis membranes are most 
effective in collecting analytes one fifth to one sixth of the MW cutoff (29).   
 Following probe construction, the tubing attached to the membrane, or catheters, are 
attached to a perfusion pump in order to control the flow of perfusate. It is necessary to assess 
both flow into and out of the membrane, as several molecules, especially those of larger 
molecular weights, are sensitive to pressure changes (18). In instances where multiple probes 
have been placed, flow rate should be consistent across all probes. An increase in flow rate will 
increase the amount of dialysate collected, but diminish the relative recovery of an analyte across 
time (51). Slower flow rates increase level of equilibrium reached between probe and the 
surrounding environment, but decrease dialysate collection and add difficulty to analysis of 
analyte concentration.  
Perfusate typically mimics normal physiological conditions with lower concentrations of 
endogenous compounds (ex. Saline, Ringer’s solution) so as not to disrupt the environment of 
the tissue of interest. Preservative agents, such as antioxidants, can be added to the perfusate to 
aid in the recovery of specific analytes. These typically do not perfuse across the membrane, 
eliminating the possibility of affecting the surrounding tissue environment (51). Delivery of 
exogenous compounds is also possible, known as ‘retrodialysis’ (21). The diffusion of the 
perfusate containing a known concentration of an exogenous compound is measured. The 
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assumption is made that analytes diffuse at the same rate from the perfusate as those within the 
target site.  
The Low-Flow- Rate method, demonstrated by Jacobson et. al, was one of the earliest 
descriptions of the relationship that existed between flow rate and membrane length. This 
investigation established the relationship between lower flow rates and an increase in yield of 
relative recovery. As flow rates decrease closer to zero, equilibrium most closely resembles that 
found within the tissue (22). This method yields low levels of dialysate and increases the length 
of the collection period due to low volume. It is also necessary to have instruments and 
equipment with increased sensitivity for proper analysis. This may lead to increased errors of 
analysis and degradation of biological components being investigated. 
Human vs. Animal Model 
         Investigations centered on microdialysis have become common in both human and 
animal models. In humans, the periphery, including skin and muscle, have been the main focus 
of dialysate collection. Studies concerning the brain have been conducted in individuals with 
brain injuries specifically due to the difficult nature of probe placement, longevity of 
experimental protocols and the awareness of human subjects (4, 10, 28). Assessment of brain 
tissue, specifically diagnosis of various neurological disorders, can be completed using 
microdialysis. Efficacy and bioavailability of pharmacological interventions has also been 
explored (35). Investigations within skeletal muscle and subcutaneous skin assessments have 
become possible (15, 23, 29, 35-38). MacLean et. al were the first investigators to apply the 
microdialysis technique to dynamic exercise in humans. Using knee extensor exercise, their 
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investigation assessed glucose and lactate concentration and the ability of microdialysis probes to 
continue recovery at rest and during activity (20, 38).  
Significant research has occurred in the animal model of microdialysis experiments. 
Multiple species have been investigated in the brain, skin, muscle, fat and several other tissue 
sites. Similar blood brain barrier transport properties and the ability to successfully predict target 
site concentrations in humans based on rat data have been noted in several investigations (5, 16, 
31).  
Interstitial Space 
Measurement of interstitial fluid at the site of the muscle, allows for data representing the 
unbound concentration of muscle derived compounds available to act on receptors specifically 
(15, 30, 36, 37). The environment of the muscle most accurately represents activity of the 
afferents, as levels of metabolites and synthetization of other proteins and enzymes may be 
watered down if measured from a site of systemic activity such as the jugular vein. 
 While much of microdialysis has been focused on chronic pain, receptor expression and 
metabolite activity that affects the pain response also combine to produce the exercise pressor 
reflex (EPR) (26, 52). In the diseased state, metabolic by products of arachidonic acid, are 
upregulated and act to sensitize group III and IV afferents (7, 30). Increased receptors 
expression, increased binding affinity, and a lower threshold of activation are potential systemic 
responses to chronic inflammation. Inflammation is associated with multiple forms of 
cardiovascular disease, including peripheral artery disease (PAD).  
Peripheral Artery Disease 
 PAD is defined by the buildup of atherosclerotic plaque within the vasculature, typically 
supplying the lower limb. This leads to the ability to maintain perfusion of skeletal muscle at rest 
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but an inability to increase blood flow during activity (17). Changes in the vasculature supplying 
the lower limb occur in an effort to increase blood supply to the tissue. While density of micro 
vessels may increase in PAD, it is not sufficient to offset the lack of perfusion during activity (2). 
These adaptations can improve exercise tolerance, even if oxygen delivery is not increased. 
Increases in collateral flow are able to continue delivery of flow further downstream, mitigating 
the effects of ischemia at rest. Treatment options during PAD, including exercise and some 
pharmacological interventions, may act to ‘induce’ the expansion of vasculature to improve 
blood flow and oxygen delivery (17, 34, 63).  
Multiple animal models have been used in an effort to further our understanding of PAD 
(17, 27). A rat model of simulated PAD in which the femoral artery is tied off (ligated), mimics 
blood flow patterns of those found in human subjects where perfusion of resting muscle 
experiences modest to no effect with ligation (2, 9). The exercise pressor reflex is also 
augmented in this rat model of PAD, but only during contraction of the musculature of the 
ischemic limb (17, 54). Both mechanically-mediated (mechanoreceptor) and metabolically-
mediated (metaboreceptor) afferents are affected. Over activation of the mechanoreflex is 
thought to contribute to the underlying mechanism of the augmented EPR in multiple forms of 
cardiovascular disease (43, 44, 45). 
Substantial build-up of inflammatory markers occurs within 3 days of limb ischemia in 
the ligated rat model of PAD (8). Pathways associated with inflammation may act to sensitize 
group III afferents, or increase signaling from mechanically activated receptors. The 
cyclooxygenase (COX) pathway has been linked to EPR dysfunction in PAD (44). When 
considering how this interaction occurs, an increase in COX metabolites may mediate the 
chronic sensitization of the mechanoreflex evident in PAD. It is also possible that over 
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expression of receptors associated with this pathway occur or further adaptations in second 
messenger systems. Increasing the understanding of metabolite production and changes across 
time may over insight into the functional alterations of the EPR in PAD.  
Conclusion  
Microdialysis is a cost effective, minimally invasive experimental technique that can be 
used in a variety of experimental protocols. The ability to assess concentrations of multiple 
biological compounds allows investigators to quantify changes in concentration in response to 
activity, disease, and pharmacological interventions. Continued improvements in probe 
constructions and design have expanded the applicability of this technique. Future directions 
may lead to better understanding of maladaptation in disease at the systemic and local level, 
allowing investigators to further tease apart the mechanistic underpinnings of physiological 
dysfunction.  
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Chapter 2 - Introduction 
Autonomic adjustments at the onset exercise include decreased parasympathetic 
activation of the heart, with an increase in sympathetic stimulation of the heart and other organs/ 
vascular beds. These are mediated in part by the exercise pressor reflex, a neural feedback 
mechanism activated by the stimulation of group III and group IV afferents, whose sensory 
endings are located within contracting skeletal muscle. These classes of afferents are primarily 
mechanically and metabolically sensitive, respectively (1, 11, 25, 40). Activation of the exercise 
pressor reflex leads to an increase in perfusion of the working muscle. Increased metabolic 
demand mediated by muscle ischemia led to long-standing interest in the metabolic component 
of this feedback mechanism (i.e., metaboreflex). Recent investigations into the mechanically 
mediated arm of the reflex (i.e., mechanoreflex) have found that alterations in group III afferent 
signaling augment reflex responses found in several forms of cardiovascular disease (32, 41, 43-
45, 53). 
The arachidonic acid cascade, primarily cyclooxygenase 1 and 2 (COX-1 and COX-2) is 
a key mediator in activation of both the metabo- and mechanoreflex. COX activity produces 
thromboxanes and prostaglandins, leading to accumulation of these metabolites in skeletal 
muscle during activity (50). In healthy human and animal subjects, a link between COX 
metabolites and responsiveness of the mechanoreflex has been demonstrated during exercise (12, 
19, 42). Mechanoreflex over activation specifically underlies the augmented reflex responses to 
activity found in hypertension (32), heart failure (41, 43), and peripheral artery disease (44). 
Metabolically mediated sensitization of the mechanoreflex has been linked directly to the COX 
pathway in heart failure and PAD. COX inhibition in both conditions attenuates the reflex 
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response to mechanoreflex activation, suggesting a correlation between a buildup of COX 
metabolites, such as PGE2, and an increased sensitization of group III afferents (14, 41-44). 
Microdialysis is an experimental technique in which a probe containing a semi-permeable 
membrane is inserted directly into the muscle. Fluid termed ‘dialysate’ is collected and can be 
analyzed to determine metabolite concentration within the interstitium (57). Metabolites in this 
space act directly on the sensory endings of afferents located within contracting skeletal muscle 
(42). This technique measures dynamic changes over time, allowing assessment of basal levels 
of various muscle derived compounds and shifts in concentration in response to activity. 
Recently our lab demonstrated a significant increase in the production of PGE2 in healthy rats 
during isolated mechanoreflex activation via passive tendon stretch using microdialysis. In this 
same investigation, COX inhibition via indomethacin (a non-selective COX inhibitor) did not 
affect the pressor response to primarily mechanically mediated reflex activation (49). These 
findings are in agreement with Muller et. al in which systemic inhibition of COX via ketorolac, a 
non-selective COX inhibitor, decreased reflex responses to mechanoreceptor activation in human 
subjects with peripheral artery disease but not healthy counterparts (44).  
While COX mediated sensitization plays a role in the augmented reflex response to 
activity in humans with PAD, it is difficult to determine the location of this sensitization due to 
systemic drug delivery. It is also difficult to determine the role of the mechanoreflex specifically, 
as it is impossible to definitively isolate activation of group III afferents in human subjects. 
Passive limb movement with human subjects introduces possible error during investigations due 
to the effect of perceived effort and mental state, activation of unintended muscle groups during 
activity, and increased inter-subject variability.  
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The use of an animal model to study the pressor response to activity, allows investigators 
to activate the mechanoreflex in the absence of contraction-induced metabolites. Ligation of the 
rat hindlimb is a model of simulated PAD, in which the femoral artery is ‘tied off’ or occluded 
~72 hours prior to an experiment. This animal model of PAD mimics the increased sympathetic 
nerve responses and augmented exercise pressor reflex found in human subjects (27, 54). 
Functional alterations in the vasculature also lead to a reduction in blood flow where perfusion is 
able to meet the demands of skeletal muscle at rest but not during activity (48, 62-64). 
In recent experiments, our laboratory found that indomethacin (a non-selective COX 
inhibitor) attenuated the pressor response in ligated rats during hindlimb muscle stretch, a model 
of isolated mechanoreflex activation in the absence of contraction induced metabolites. This data 
suggests COX mediated-mechanoreflex sensitization occurs with chronic femoral artery ligation 
in the rat, similar to results found in human PAD counterparts who saw an attenuation of the 
EPR during plantar flexion exercise with COX inhibition. (44). 
While the COX pathway plays a role in over activation of the mechanoreflex in PAD, 
where in this pathway sensitization occurs has yet to be identified. A potential mechanism is a 
build-up of COX metabolites. In the current investigation, we sought to determine if the 
augmented mechanoreflex found in PAD occurred due to chronic sensitization from a difference 
in resting levels of PGE2 in a ligated rat model of simulated PAD when compared to freely 
perfused hindlimbs. We hypothesized that the concentration of PGE₂ in muscle microdialysate 
would be elevated at rest in ligated hindlimbs. We also investigated the effect of ligation on 
production of PGE₂ within the rat hindlimb during mechanoreflex activation via dynamic passive 
tendon stretch. Based on our previous findings, we hypothesized that an exaggerated increase in 
11 
PGE₂ would occur in ligated rat hindlimbs with isolated mechanoreflex activation using dynamic 
passive tendon stretch.  
. 
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Chapter 3 - Methods 
All experimental procedures were approved by the Institutional Animal Care and Use 
Committee of Kansas State University and conducted in accordance with the National Institutes 
of Health Guide for the Care and Use of Laboratory Animals. In vivo experimental techniques 
were performed on young adult (~12-15 weeks) male Sprague- Dawley rats (n=15, average body 
weight: 459±11 g, Charles River Laboratories). Rats were housed two per cage in temperature 
(maintained at ~22 °C) and light (12-12-hour light-dark cycle running 7 AM to 7 PM) controlled 
facilities. Standard rat chow and water was provided ad libitum. At the end of these experiments, 
the decerebrated rats (see below) were killed by an intravenous injection of saturated (>3 mg/kg) 
potassium chloride.   
 
Surgical Procedure: Twelve of the 15 rats used in this investigation had their left femoral artery 
ligated (referred to as “ligated rats” from this point forward for simplicity) 72-96 hours before 
the experimental protocol. Rats were briefly anesthetized with ~3% isoflurane (balance O₂). The 
left femoral artery was then surgically exposed and ligated tightly with 5-0 silk suture ~3-5 mm 
distal to the inguinal ligament. The incision was then closed and meloxicam (1-2 mg/kg sc) was 
administered as an analgesic.   
          On the day of the experiment, rats were anesthetized. Adequate depth of anesthesia was 
confirmed by the absence of toe-pinch and blink reflexes. The trachea was cannulated, and the 
lungs were mechanically ventilated (Harvard Apparatus, Holliston, MA) with a 2% isoflurane-
balance O₂ mixture until decerebration was complete (see below). In all rats, the right jugular 
vein and both common carotid arteries were cannulated with PE-50 catheters for the 
administration of fluids, measurement of arterial blood pressure (Physiological Pressure 
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Transducer, AD Instruments), and sampling of arterial blood gases. For all experiments, the skin 
covering the left hindlimb was cut and reflected to expose triceps surae (gastrocnemius, soleus 
and plantaris) muscles. In 12 rats, this procedure was completed on both hindlimbs. For stretch 
experiments (n=10), a string was attached to the Achilles tendon and the calcaneus was severed. 
The triceps surae muscle was then linked to a force transducer (Grass FT03) which was attached 
to a rack and pinion. 
          Following completion of the initial surgical procedures, all rats were placed in a Kopf 
stereotaxic frame. Dexamethasone (0.2 mg i.v.) was administered to minimize swelling of the 
brainstem. A precollicular decerebration was performed and all neural tissue rostral to the 
superior colliculus was removed. Once decerebration was complete, anesthesia was terminated 
and the lungs were ventilated with room air. Decerebration was performed because anesthesia 
dampens the exercise pressor reflex in the rat. Arterial blood gases and pH were measured with a 
blood gas analyzer (ABL80 Flex, Radiometer) and maintained within normal physiologic 
parameters (PaCO₂: 35-45 mmHg, PaO₂: ~100 mmHg, pH: 7.35-7.45) by adjusting ventilation 
and/or administering intravenous sodium bicarbonate (8.5%). Core temperature was measured by 
a rectal probe and maintained at ~37-38 ℃ by an automated heating system (Harvard Apparatus) 
and a heat lamp. 
 
Probe Construction Microdialysis probes were constructed by gluing both ends of a pre-
measured membrane (Spectra/Por®, 13-kDa molecular cutoff) to PE tubing, with one end 
attached to a syringe hub. In protocol 1, membrane lengths used included 1 cm, 1.75 cm, and 2 
cm. Following results of these experiments, all other probes were constructed using a membrane 
measuring 1.75cm. On the day of each experiment, membranes were flushed with ethanol to 
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‘activate’ the membrane. Activation of membranes is required, as they are purchased containing 
a filling liquid to ensure structural integrity and protect the membrane. This liquid is alcohol 
soluble. A second flush of distilled water or perfusate solution removes traces of ethanol, and 
ensures the probe is ready for placement. 
 
Protocol 1- Three microdialysis probes with semi-permeable membranes were placed and 
attached to a perfusion pump. All membranes were completely submerged in a lactate solution in 
a dish and allowed sufficient time to reach equilibrium. Concentration of the lactate solution was 
known, and measurements were taken throughout the duration of the protocol to ensure that 
concentration was similar across time. The solution was stirred using a mixing plate at a low 
speed to keep the solution consistent throughout. Flow rates ranging from 2.5- 40 µl/min were 
used, with lactate measurements taken immediately as dialysate was produced. Measurements 
were taken in duplicate using a lactate analyzer for each measured flow rate. Averages of these 
values were calculated and analyzed. 
 
Muscle microdialysis Microdialysis experiments were performed on 15 rats. Probes were 
attached to a syringe filled with saline placed within a microdialysis pump to allow for constant 
infusion and controlled flow rate. Following decerebration, in 12 of 15 rats used, four 
microdialysis probes were placed within the right and left triceps surae muscle. A 20-gauge 
needle was used to puncture the muscle and guide placement of the probe. In each hindlimb, two 
probes were placed within the medial gastrocnemius, one in the lateral gastrocnemius, and one 
within the soleus muscle (see Fig.1). This was chosen in order to sample each muscle fiber type 
15 
and represent total activity of the hindlimb. Sufficient recovery time (~120 minutes) was allowed 
following probe placement before fluid collection began.  
 
Protocol 2- Following the previous investigation, membranes of 1.75 cm were placed within the 
triceps surae muscles of the left hindlimb as described above (n=3). Dialysate from all probes 
was pooled into a single collected sample for immediate analysis. Lactate measurements were 
recorded using the same analysis technique from the previous protocol. Measurements at flow 
rates ranging from 2.5-40 µl/min were recorded in duplicate. 
 
Protocol 3- Following establishment of a protocol in vivo, 1.75 cm length probes were placed in 
the same location (see Fig. 1), and constantly infused with saline at 5 𝜇l/min. In rats with a 
ligated model of simulated PAD, probes were placed within both the freely perfused and ligated 
hindlimb, to allow within animal comparisons between conditions. Collection tubes were placed 
within a cold block to slow the degradation of the biological components of the dialysate. A 90-
minute recovery period was used prior to muscle microdialysate fluid collection, following no 
significant difference in resting PGE₂ values assessed at 60 minutes post probe placement and 
120 minutes post probe placement. We utilized a 90-minute waiting period following these 
findings to maintain consistency throughout each investigation. Following collection of dialysate 
at rest, baseline tension was set to 80-100g of tension. Fluid was collected for four minutes to 
analyze pre-stretch baseline. In random order, freely perfused and contralateral ligated hindlimbs 
were dynamically stretched for four minutes.  
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 A skilled investigator from our laboratory, rhythmically turned a rack and pinion at 1 Hz 
achieving similar tension with each stretch for 4 minutes. This length of stretch was chosen to 
ensure that enough dialysate was produced for analysis of samples.  A ~10-minute recovery 
period was used between maneuvers. Following this recovery period, the stretch protocol was 
repeated with the opposite hindlimb. Dialysate tubes were stored in a cold block during 
collection. In order to account for dead space and ensure dialysate collected represented the 
composition of the interstitial space during stretch, fluid collection did not begin until ~2-
minutes following the initiation of the stretch protocol.  
Our laboratory had previously conducted control experiments using Evans Blue dye in 
which we measured the time for the dye to travel through the muscle, into the probe, and emerge 
as dialysate for collection. During stretch experiments, fluid was also collected for four minutes 
following completion of the stretch protocol, as this dialysate was within the muscle at the time 
of interest. Following collection, all samples were immediately stored at – 80 °C. Analysis of 
fluid was completed using a commercially available PGE₂ ELISA kit (Arbor Assay) using the 
low-sample volume yield protocol. To construct the standard curve, samples were ran in 
triplicate. Dialysate collected at rest was ran in duplicate. The coefficient of determination (r²) of 
the standard curve across all assays was 1 (range 0.99-1). Average coefficient of variation of 
duplicate samples across all assays was 5% (range 3-9%). 
 
Data Analysis Data was collected with a PowerLab and LabChart data acquisition system (AD 
Instruments). Blood pressure, muscle tension and ECG were measured and recorded in real time. 
Mean arterial pressure (MAP) and heart rate (HR) were calculated and displayed in real time, 
and recorded for offline analysis. The Δ tension time index (Δ TTI) was calculated for each 
17 
maneuver by integrating the area under the tension signal during the stretch protocol and 
subtracting the integrated area during the baseline period. The 30-second baseline TTI was 
multiplied by the appropriate factor to equate it to the duration of stretch. All values are 
expressed as mean ± SE. Data was analyzed using paired student’s t-test and repeated-measures 
ANOVAs with Holm-Sidak post hoc tests. Statistical significance was defined as p ≤ 0.05.  
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Figure 1: Probe placement during muscle microdialysis 
Schematic illustrating placement of microdialysis probes during each experiment following 
surgical separation of the rat hindlimb. Probes A and B were placed in the medial gastrocnemius. 
Probe C was placed in the lateral gastrocnemius and probe D was placed in the soleus. Dialysate 
from all four probes was pooled into a single sample for immediate analysis during lactate 
experiments. All dialysate was pooled in a single collection tube for storage until use for analysis 
during experiments measuring PGE₂ concentration, at rest and during mechanoreflex activation 
via passive tendon stretch.  
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Chapter 4 - Results 
Protocol 1: Effect of probe length and flow rate on Lactate 
Probes measuring 1cm, 1.75 cm and 2 cm were constructed in order to measure the 
effects of probe length and flow rate on diffusion of lactate. As probe length increased, relative 
recovery of lactate from the lactate bath also increased. An inverse relationship became evident 
as flow rate increased, the recovery of lactate decreased. (See Fig.2) This relationship was true 
across all membrane lengths. Similar recovery was measured between 1.75 cm and 2 cm length 
membranes across multiple flow rates (Fig. 2). This protocol served as a control to assess the 
ability of our method to measure the concentration of an analyte of interest. A flow rate of 5 
µl/min was chosen for future microdialysis investigations, as it yielded the greatest concentration 
of lactate (1.7 mmol) while still allowing for the greatest collection of dialysate fluid. Slower 
flow rates allow greater diffusion to occur, but decrease the amount of dialysate collected. Small 
amounts of fluid produced make quantification difficult and poses the challenge of degradation 
of the analytes of interest (29) 
Protocol 2: Lactate measurements in vivo 
Based on the results of the previous experiments, we selected a membrane length of 1.75 
cm for use in measuring lactate concentration within the hindlimb. This membrane length was 
chosen to ensure the membrane was completely encapsulated within the hindlimb. Experiments 
were performed in three rats. Lactate has been investigated extensively with the microdialysis 
technique, during activity and at rest. (37) With an increase in flow rate, there was a reduction in 
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lactate recovered from the hindlimb (see Fig. 3). Results of these experiments confirmed the 
ability to measure metabolite concentration within the rat hindlimb.  
Protocol 3: PGE₂ measurements 
 In 12 rats, experiments were conducted to compare resting concentrations of PGE₂ 
between freely perfused and contralateral ligated hindlimbs. There was no significant difference 
in resting muscle microdialysate fluid PGE₂ concentration between freely perfused (196±33 
pg/ml) and the contralateral hindlimb that had been previously ligated (236±43 pg/ml, p=0.15)). 
(See Fig 4). Baseline MAP (freely perfused: 76±9, ligated: 78±91, p=0.09) and baseline heart 
rate (freely perfused: 443±41, ligated: 457±39, p=0.22) were not significantly different between 
freely perfused and ligated rats during dialysate collection.  
  In 10 of these 12 rats, we performed a dynamic stretch protocol to isolate mechanoreflex 
activation within freely perfused and contralateral ligated hindlimbs. In this subset of rats, 
changes in PGE₂ concentration from rest to stretch were quantified. Following the stretch 
protocol, a significant increase in PGE2 above baseline levels occurred in the freely perfused 
hindlimb (p=0.05) (Fig. 5), while there was no stretch-induced increase in PGE2 in the ligated 
hindlimb (p=0.98) (Fig. 5). The ΔTTI of the stretch maneuvers was not different between 
hindlimbs (p=0.35). Baseline HR (freely perfused: 444±41, ligated: 461±41, p=0.22) and 
baseline MAP (freely perfused: 72±8, ligated: 74±9, p=0.09) were not significantly different 
between freely perfused and ligated rats during stretch.  
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Figure 2: Effect of membrane length and flow rate on lactate recovery 
 A and B as membrane length (cm) increased, concentration (mmol) and relative recovery (% 
gain) of lactate within microdialysate fluid also increased. An inverse relationship became 
evident across all membrane lengths, as an increase in flow rate (µl/min) negatively affected 
lactate readings. Lactate measurements were taken in duplicate and mean values are reported. 
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Figure 3: Relative recovery of lactate in vivo 
As flow rate increased, the amount of lactate (mmol) recovered in muscle microdialysate fluid 
from the triceps surae muscle decreased. Flow rates tested varied from 2.5-40 µl/min. At 40 
µl/min, lactate readings were below the detectable range of the lactate analyzer used. 
Measurements were taken in duplicate with mean values expressed. 
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Figure 4: Resting concentration of PGE₂ in freely perfused and ligated hindlimbs  
No significant difference (n=12) was found between resting concentration of PGE₂ within 
microdialysate fluid collected from freely perfused (196±33 pg/ml) and ligated (236±43 pg/ml) 
hindlimbs (p=0.15). Values are mean ±SE. Data were analyzed with a paired student’s t-test. 
Statistical significance was accepted at p≤0.05. 
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Figure 5: Measured increase of PGE2 concentration with mechanoreflex activation 
Dynamic stretch increased the concentrations of PGE2 within muscle microdialysate fluid above 
resting levels (n=10) in freely perfused hindlimbs (p=0.05) but not ligated hindlimbs (p=0.98). 
Muscle tension produced during the stretch maneuver was not different between hindlimbs. 
Values are mean ± SE. Data were analyzed with a 2-way RM ANOVA with Holm-Sidak post 
hoc tests. Statistical significance was accepted at p≤0.05. 
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Chapter 5 - Discussion 
Novel findings of our investigation include: 1.) Resting levels of interstitial PGE2 
concentration are not elevated in the ligated rat hindlimb compared to freely perfused ‘healthy’ 
counterparts and 2.) Increases in PGE2 during mechanoreflex activation via passive dynamic 
hindlimb stretch are not exaggerated in a ligated rat model of simulated PAD.  
In protocol 1 and 2, we established a muscle microdialysis protocol for use in the ligated 
rat model of simulated PAD. Microdialysis investigations are commonly used in the brain, 
primarily analysis of pharmacological interventions (4-6, 13, 16, 29, 51). We utilized this 
technique to assess the environment acting on group III and group IV afferents to gain further 
insight on the mechanistic adaptations that occur in response to disease.  
This investigation began by assessing the ability to construct microdialysis probes and 
determine the relationship that existed between membrane length and flow rate. A curvilinear 
relationship became evident across all membrane lengths (1 cm, 1.75 cm, and 2 cm). As flow 
rate increased the concentration of lactate recovered decreased. Following the ability to 
successfully measure lactate concentrations using a standard lactate solution with a known 
concentration, we transitioned to using microdialysis probes in vivo.  
During this protocol, we assessed the ability of our probes to diffuse a known metabolite 
within skeletal muscle. Lactate has successfully been investigated with the microdialysis 
technique within a variety of tissues (35, 46). A relationship between flow rate and membrane 
length was further confirmed. Slower flow rates also yielded greater concentrations of measured 
lactate within muscle dialysate. A curvilinear relationship was evident. Following successful 
measurements of a metabolite across time and distinguishing different concentrations, we 
progressed to measuring PGE₂ concentration in the hindlimb of freely perfused and ligated rats.  
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Microdialysis has also been used to assess concentrations of prostaglandins in human 
subjects (24). COX-mediated sensitization of the mechanoreflex has been demonstrated in 
various forms of cardiovascular disease (41, 43, 44, 50). Our laboratory found that COX 
inhibition with indomethacin (a non-selective COX inhibitor), significantly reduces the reflex 
response to passive tendon stretch in a ligated rat model of simulated PAD. Reduction of the 
pressor response confirmed that COX-mediated sensitization of the mechanoreflex occurs with 
ligation. Synthesis of PGE2 as it relates to baseline levels within skeletal muscle has previously 
been suggested as the rate-limiting step of COX inhibition.  
We sought to determine if elevated concentrations of PGE2 within the interstitial space of 
the rat hindlimb acts to sensitize the mechanoreflex with ligation. We have shown that resting 
levels of PGE₂ are not significantly different between freely perfused and contralaterally ligated 
hindlimbs. While these findings refute our initial hypothesis, these are in line with Leal et. al, 
who measured resting levels of TXB₂ (another COX metabolite) and found no significant 
difference in resting levels between freely perfused and ligated hindlimbs (33). Paired with our 
findings, we conclude that an increase in resting levels of COX metabolites is not the mechanism 
underlying chronic sensitization of the mechanoreflex in a rat model of simulated PAD. 
Mechanical stimulation of skeletal muscle creates an increase in PGE2 efflux leading to 
accumulation of this metabolite, and this efflux may play a key role in activation of reflex 
responses to activity (24). Previous findings from our laboratory utilizing passive tendon stretch 
in freely perfused animals, demonstrated a significant increase above baseline levels of PGE₂ 
produced during stretch. Rollins et al, demonstrated that COX inhibition via indomethacin (a 
non-selective COX inhibitor) had no effect on reflex responses to mechanoreflex activation in 
freely perfused, ‘healthy’ rats (49). With the knowledge that COX mediated sensitization 
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occurred during ligation, we measured if there was an exaggerated increase of PGE₂ during 
passive tendon stretch in the ligated hindlimb compared to freely perfused counterparts.  
Following a ~4 min passive tendon stretch protocol to isolate mechanoreflex activation in 
the absence of contraction induced metabolites, a significant increase in the concentration of 
PGE₂ occurred in freely perfused but not ligated hindlimbs. This was an important confirmation 
of our previous findings in freely perfused rats, but also demonstrated there is not an exaggerated 
increase in PGE₂ concentration during isolated mechanoreflex activation following ligation of 
the femoral artery. No difference in metabolite concentration without the aid of drug intervention 
suggests that an over activity in production is not the rate limiting step of chronic sensitization.   
While resting levels of PGE₂ and synthesis during stretch of PGE₂ are not different 
between freely perfused and ligated rats, there are multiple sites within the COX pathway that 
may serve as the mediator to chronic sensitization of the mechanoreflex.  Receptors expressed 
within group III afferents demonstrate binding affinity to several metabolites including PGE2, 
thromboxanes and leukotrienes (45).  Leal et. al demonstrated, in the same study previously 
mentioned, that blockade of the TP receptor (part of the COX pathway, acted on by 
thromboxanes) with daltroban, in both health and disease, attenuated the cardiovascular reflex 
responses to stretch (33). Yamauchi et. al demonstrated that blockade of Endoperoxide 4 (EP4) 
receptors (acted upon directly by PGE2) in PAD was able to attenuate the reflex response during 
contraction. This investigation showed no effect of EP4 blockade in health, suggesting a role in 
the transition to disease (59). While both classes of receptors are involved in producing the 
exercise pressor reflex during health, EP4 receptors play a larger role in augmenting the 
mechanoreflex in PAD. Adaptations within skeletal muscle may include over-expression of 
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multiple receptor types or an increased binding affinity. It is also possible that sensitization 
occurs due to a lower threshold of activation of each receptor. 
 Group III afferents demonstrate increased sympathetic out-pouring to mechanical 
deformation and sensitivity to metabolite build up at the onset of activity (19, 25, 44, 50).  While 
resting levels of PGE₂ concentration were not elevated in the ligated hindlimb, it is possible that 
chronic sensitization occurs due to accumulation of another metabolite. Certain receptors may 
also display increased sensitivity to metabolites depending on the progression and severity of 
disease.  
Changes in pathway function of the EPR have been noted in varying stages of heart 
failure (HF), also characterized by mechanoreflex over activation. (41, 43). The COX pathway 
has also been implicated as playing a direct role in chronic sensitization of the mechanoreflex 
during HF. Morales et al. recently demonstrated a reduction in mechanoreflex responsiveness 
with the use of a selective COX-2 inhibitor in HF. (43). Over expression of COX-2 but not 
COX-1 has been found in skeletal muscle of patients with HF (3). Paired with the findings from 
our present investigation, differentiating the enzymatic activity and protein expression of COX 1 
and 2 may be beneficial in PAD. Targeted treatments may prove more effective when 
considering the COX pathway completely.  
Limitations An important limitation of our study is simulated PAD with femoral artery 
ligation. In a clinical setting, PAD occurs overtime, while the model used in this investigation 
occurs in ~72 hours. Previous investigations from our laboratory (27) have shown similar 
increases in the augmented reflex response, as those measured in humans with PAD (27, 54). 
Adaptations in collateral flow in the rat model of PAD mimic those found in human subjects and 
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the ability to maintain muscle perfusion at rest but not with the onset of activity is also similar 
(17, 48, 60-62). 
It is also possible that the length of our stretch protocol impacted measurements of PGE2 
synthesis.  A standard 30 sec protocol to activate the mechanoreflex could not be used, due to 
utilizing the microdialysis technique. In order to collect enough fluid for analysis, a longer 
stretch protocol was required. Dilution of recovered metabolites seems unlikely. If exaggerated 
production of PGE₂ occurred during the initial phase of stretch, it is likely that this would extend 
throughout the remaining portion of the stretch protocol. 
Perspectives and Significance Our study suggests that while cyclooxygenase products 
may play a role in sensitization of group III afferents in the ligated rat model of PAD, this is not 
due to elevated resting levels of PGE₂ or an exaggerated increase in PGE₂ concentration during 
isolated mechanoreflex activation. Assessment of receptors tied to activation of group III 
afferents and quantification of protein expression associated with the COX pathway may serve as 
future directions in gaining further insight into the mechanisms underlying the augmented 
mechanoreflex in PAD.  
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